Earnings · China A-shares
Fujian Cosunter Pharmaceutical Co., Ltd. Class A (300436) earnings
Fujian Cosunter Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-27: net profit +7.19% year on year, +6.70% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved +2.17% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-27
- Period end
- 2026-09-30
- Net profit YoY
- +7.19%
- Excl. one-offs YoY
- +6.70%
- Result
- Bad / loss
- Quality score
- 59
- Quality
- Questionable
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +4.37% | — |
| 3 days | +2.17% | — |
| 7 days | +10.08% | — |
| 14 days | -0.14% | — |
Report history
Over the last 8 reports, net profit grew year on year in 3 of them. The stock rose in the 3 trading days after 5 of 7 reports (average +2.01%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-28 | -¥103.56M | +7.19% | +6.70% | +4.08% | -0.65 | -34.00% | +2.17% | — | — |
| 2026 interim report | 2026-08-29 | -¥68.14M | -2.18% | -1.53% | +5.41% | -0.43 | -27.99% | -2.52% | -17.43% | -8.09% |
| 2026 Q1 report | 2026-04-29 | -¥25.92M | +9.00% | +6.43% | +0.85% | -0.16 | -9.80% | +11.36% | -18.58% | -19.52% |
| 2025 annual report | 2026-04-29 | -¥217.85M | -39.37% | -13.02% | -5.68% | -1.37 | -76.42% | +11.36% | -18.58% | -19.52% |
| 2025 Q3 report | 2025-10-30 | -¥111.58M | -57.96% | -40.81% | -3.21% | -0.70 | -36.66% | +5.33% | -18.88% | -14.13% |
| 2025 interim report | 2025-08-22 | -¥66.69M | -85.05% | -46.97% | -4.27% | -0.42 | -20.40% | +2.19% | -29.40% | -37.20% |
| 2025 Q1 report | 2025-04-25 | -¥28.49M | -94.56% | -71.52% | -18.69% | -0.18 | -8.24% | -8.47% | +11.06% | +7.81% |
| 2024 annual report | 2025-04-18 | -¥156.30M | +55.16% | +43.67% | +4.43% | -0.98 | -35.66% | +4.03% | +17.50% | +14.60% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.